OCTA in Epivascular Glia After Dex Implant
NCT05600179 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38
Last updated 2022-12-08
Summary
The aim of this prospective study was for the first time, to analyze specific morphologic features in diabetic eyes with macular oedema, such as changes of the foveal avascular zone and the presence of epivascular glia, and see how they would change after dexamethasone intravitreal implant
Conditions
Interventions
- DRUG
-
Dexamethasone intravitreal implant
Dexamethasone intravitreal implant
Sponsors & Collaborators
-
Federico II University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2022-09-30
- Completion
- 2022-09-30
Countries
- Italy
Study Locations
More Related Trials
-
Effect of Dexamethasone Implant on Optic Disc
NCT03927118 ·Status: COMPLETED
-
Research Study in Patients With Persistent Macular Edema
NCT00035906 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema
NCT05343156 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
NCT00308477 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
NCT02121197 ·Status: COMPLETED
-
Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial
NCT03608839 ·Status: COMPLETED ·Phase: PHASE2
-
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)
NCT06172257 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema
NCT04448496 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema
NCT00308542 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema
NCT02121262 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
NCT06984822 ·Status: RECRUITING ·Phase: NA
-
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
NCT00168324 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective Study
NCT02804360 ·Status: UNKNOWN ·Phase: PHASE2
-
Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection
NCT05003258 ·Status: COMPLETED ·Phase: NA
-
Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema
NCT04089605 ·Status: COMPLETED ·Phase: PHASE4
-
Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema
NCT04910503 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema
NCT01698749 ·Status: COMPLETED ·Phase: NA
-
Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS)
NCT01030601 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema
NCT05736081 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema
NCT00799227 ·Status: COMPLETED ·Phase: PHASE2
-
Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.
NCT06846073 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema
NCT00168389 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO
NCT02006147 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
NCT04563299 ·Status: TERMINATED ·Phase: PHASE4
-
Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane
NCT02995746 ·Status: TERMINATED ·Phase: NA